Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.verified

LXRX

Price:

$1.62

Market Cap:

$585.62M

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.[Read more]

Industry

Biotechnology

IPO Date

2000-04-07

Stock Exchange

NASDAQ

Ticker

LXRX

The PE Ratio as of May 2024 (TTM) for Lexicon Pharmaceuticals, Inc. (LXRX) is -1.95

According to Lexicon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.95. This represents a change of -11.00% compared to the average of -2.19 of the last 4 quarters.

Lexicon Pharmaceuticals, Inc. (LXRX) Historical PE Ratio (quarterly & annually)

How has LXRX PE Ratio performed in the past?

The mean historical PE Ratio of Lexicon Pharmaceuticals, Inc. over the last ten years is -33.69. The current -1.95 PE Ratio has changed 478.87% with respect to the historical average. Over the past ten years (40 quarters), LXRX's PE Ratio was at its highest in in the December 2015 quarter at 3.97. The PE Ratio was at its lowest in in the December 2014 quarter at -46.05.

Quarterly (TTM)
Annual

Average

-33.69

Median

-5.61

Minimum

-294.49

Maximum

3.39

Lexicon Pharmaceuticals, Inc. (LXRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lexicon Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.97%

Maximum Annual PE Ratio = 3.39

Minimum Annual Increase = -259.45%

Minimum Annual PE Ratio = -294.49

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.91-37.77%
2022-3.07-52.79%
2021-6.5020.37%
2020-5.40-259.45%
20193.39-158.16%
2018-5.82-27.63%
2017-8.05-20.76%
2016-10.16-96.55%
2015-294.495.97%
2014-4.85-45.33%

Lexicon Pharmaceuticals, Inc. (LXRX) Average PE Ratio

How has LXRX PE Ratio performed in the past?

The current PE Ratio of Lexicon Pharmaceuticals, Inc. (LXRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.83

5-year avg

-2.70

10-year avg

-33.69

Lexicon Pharmaceuticals, Inc. (LXRX) PE Ratio vs. Peers

How is LXRX’s PE Ratio compared to its peers?

Lexicon Pharmaceuticals, Inc.’s PE Ratio is less than BioLineRx Ltd. (0), less than Ardelyx, Inc. (-0.78), greater than Seres Therapeutics, Inc. (-23.90), less than ImmunityBio, Inc. (-1.62), greater than eFFECTOR Therapeutics, Inc. (-7.30), less than X4 Pharmaceuticals, Inc. (-0.21), less than Elevation Oncology, Inc. (-1.40), greater than Mereo BioPharma Group plc (-4.62), greater than Hepion Pharmaceuticals, Inc. (-58.75), less than Galera Therapeutics, Inc. (-0.15), less than Terns Pharmaceuticals, Inc. (-0.23), greater than Day One Biopharmaceuticals, Inc. (-4.90), greater than HOOKIPA Pharma Inc. (-5.71), greater than Enveric Biosciences, Inc. (-2.11), less than CohBar, Inc. (-0.22), less than Ocean Biomedical, Inc. (-0.25), less than AVROBIO, Inc. (-0.25), less than null (2.23),

Build a custom stock screener for Lexicon Pharmaceuticals, Inc. (LXRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexicon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lexicon Pharmaceuticals, Inc. (LXRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lexicon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Lexicon Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Lexicon Pharmaceuticals, Inc. (LXRX)?

What is the highest PE Ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

What is the 3-year average PE Ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

What is the 5-year average PE Ratio for Lexicon Pharmaceuticals, Inc. (LXRX)?

How does the current PE Ratio for Lexicon Pharmaceuticals, Inc. (LXRX) compare to its historical average?